Pitch for Investment

Latest Insights, Interviews, News, and Resources.

The latest news from UKI2S and our portfolio companies

Jonathan Wogel

CEO Spotlight: Jonathan Wogel, Executive Chairman, Zentraxa

8th July 2021

Jonathan Wogel, Executive Chairman of UKI2S portfolio company Zentraxa, has a career of two halves, starting his journey in large, international corporations…
Scientist at work

Cytoseek raises £3.57m ($5m) to advance its mission to develop the next generation of cell therapies for cancer

19th March 2021

A discovery-stage biotech company developing the next generation of cell therapies to treat cancer, is excited to announce today the completion of a £3.57M ($5M) funding round.
Linear Diagnostics

University of Birmingham spin-out secures £800k for point of care diagnostics platform

24th February 2021

The second round of funding will enable the company to commence the development of the hardware platform for its tests.
Jane Dancer

NanoSyrinx strengthens board with appointment of Dr Jane Dancer as Non-Executive Director

10th December 2020

Coventry, UK, 10th December 2020 / NanoSyrinx announces the appointment of Dr Jane Dancer to its Board as Non-Executive Director.
Cows

Supporting UK agritech innovation

9th October 2020

R&D in the UK is thriving and extraordinary innovation can be found in all sectors, ranging from agritech to energy to pharma and beyond.

test tubes

Ikarovec one of Scrip’s ‘10 To Watch’ at BIO-Europe Digital, October 26-29

5th October 2020

Ikarovec, which is developing novel gene therapies to treat major ophthalmic indications, is pleased to announce that it has been named one of Scrip’s ’10 To Watch’ companies at Bio-Europe Digital.

Crescendo Biologics

Engineering Biology start up NanoSyrinx secures capital to develop its fully customisable platform for intra-cellular engineering

30th September 2020

NanoSyrinx is the first company to engineer ‘nanosyringes’, a selective non-viral peptide and protein delivery system identified in an undisclosed organism.
Device

AgPlus Diagnostics wins £230,000 in UK Government grants for COVID-19 diagnostic test development

10th September 2020

UK Innovation and Science Seed Fund (UKI2S) portfolio company, AgPlus Diagnostics, has been awarded two government grants to develop its COVID-19 assays, one for antigen detection and a serological assay to monitor immune response.

DNA

Ikarovec awarded grant by Innovate UK to develop new wet AMD gene therapy

15th June 2020

Ikarovec, which is developing novel gene therapies to treat major ophthalmic indications, has been awarded £458,740 by Innovate UK…
Lab work

GyreOx announces seed funding to develop novel therapeutics targeting intracellular proteins implicated in cancer and autoimmune diseases

11th March 2020

GyreOx Therapeutics (GyreOx), developing its novel MACRO platform, has launched today with backing from UKI2S and LifeArc.
Ikarovec

Ophthalmic gene therapy company Ikarovec launches with £2.5m seed funding

5th February 2020

Founded by UK Innovation & Science Seed Fund (UKI2S) with co-investment from LifeArc & Parkwalk to advance a diabetic macular edema gene therapy and other pipeline products.
lab work

UKI2S, Catapult Ventures and Jonathan Milner invest £500K in gene modulation newcomer Pencil Biosciences

11th December 2019

UK Innovation & Science Seed Fund (UKI2S), Catapult Ventures’ GM&C Life Sciences Fund and Jonathan Milner are pleased to announce an investment in Pencil Biosciences…
lab work

Spin out secures £1.1M for ground-breaking ‘supercharged’ cell therapies to treat solid tumours

25th November 2019

A University of Bristol spin-out company has raised £1.1 million in funding to develop next generation cell therapies that could open new ways to treat solid tumours…
Linear Diagnostics

Rapid test for gonorrhoea and chlamydia to be developed by University of Birmingham spinout

25th November 2019

University of Birmingham spinout Linear Diagnostics Ltd has raised £2m to develop a rapid test for chlamydia and gonorrhoea which can detect infection from a single sample, allowing diagnosis and treatment in a single patient visit.
Cytoseek wins Rising Star Award

CytoSeek Wins at Launch: Great West Rising Star Award

19th June 2019

UKI2S would like to congratulate CytoSeek on winning the Rising Star Award at the 1st annual Launch: Great West awards.
Quethera leaderships wins BVCA Management Team Award

Former Quethera leadership wins BVCA Management Team Award

14th June 2019

UKI2S congratulates the former management team of Quethera led by CEO Dr. Peter Widdowson and CSO Professor Keith Martin as winners of the British Venture Capital Association Management Team Award.
Seedlings

Synthace share the secrets of successful seed funding

22nd May 2019

Innovative software company Synthace is working to transform the way that scientists and companies do biology.
microbiome

CHAIN Appoints New Non-Executive Directors

10th April 2019

UK microbiome therapeutics company CHAIN Biotechnology has appointed two new non-executive directors, Dr Nel Moore and Dr Robert Haigh to the Board.
Production

UKI2S Synbio Digest

5th November 2018

Synbio Digest features news, views and reports covering the engineering biology industry and recent research.
Quethera funding story

A Fork in the Road: Quethera’s Story

23rd October 2018

UKI2S announced in August the successful exit of its portfolio company Quethera. Acquired by Japanese pharma giant Astellas for up to £85 million, the deal…
Tropic Biosciences are preventing banana extinction

The Banana is dying out. The race is on to reinvent it before it’s too late

12th October 2018

The world’s most popular fruit is facing extinction, and scientists are racing to use gene-editing to save it. To succeed, they’ll need to overcome an even bigger problem: opposition to GMO crops.
Eye closeup

Astellas Announces Acquisition of Quethera

10th August 2018

Acquisition furthers Astellas’ commitment to innovation in ophthalmology with addition of novel gene therapy program for glaucoma.
Banana

Scientists scramble to stop bananas being killed off

18th July 2018

British firm Tropic Bioscience races to produce bananas resistant to fungus sweeping global plantations.
Computer Code

Synthace Named a 2018 Cool Vendor in Life Sciences by Gartner

20th June 2018

Recognised by Leading Analyst Firm for its Laboratory of the Future Platform.
UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.

Stay updated

UKI2S
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.